Fiera Capital Corp Sells 16,200 Shares of Danaher Co. (NYSE:DHR)

Fiera Capital Corp cut its holdings in shares of Danaher Co. (NYSE:DHR) by 8.3% during the third quarter, HoldingsChannel.com reports. The firm owned 177,898 shares of the conglomerate’s stock after selling 16,200 shares during the quarter. Fiera Capital Corp’s holdings in Danaher were worth $49,459,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the business. CarsonAllaria Wealth Management Ltd. acquired a new stake in Danaher during the 2nd quarter worth $25,000. nVerses Capital LLC acquired a new stake in shares of Danaher during the second quarter worth $25,000. MFA Wealth Advisors LLC bought a new stake in Danaher in the second quarter valued at about $51,000. Financial Connections Group Inc. acquired a new position in Danaher in the second quarter valued at about $51,000. Finally, Western Pacific Wealth Management LP bought a new position in Danaher during the first quarter worth about $55,000. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Down 0.1 %

DHR stock traded down $0.14 during midday trading on Friday, hitting $245.96. The company’s stock had a trading volume of 841,038 shares, compared to its average volume of 2,734,411. The stock has a market capitalization of $177.65 billion, a P/E ratio of 46.97, a PEG ratio of 4.54 and a beta of 0.85. The company’s fifty day moving average price is $265.79 and its 200 day moving average price is $260.75. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. Danaher Co. has a twelve month low of $192.35 and a twelve month high of $281.70.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, beating the consensus estimate of $1.57 by $0.14. The firm had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.02 earnings per share. As a group, equities research analysts predict that Danaher Co. will post 7.51 EPS for the current year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were given a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of 0.44%. The ex-dividend date was Friday, September 27th. Danaher’s dividend payout ratio (DPR) is currently 20.61%.

Analysts Set New Price Targets

A number of analysts have recently commented on DHR shares. Robert W. Baird lowered their price target on Danaher from $278.00 to $277.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. Barclays cut their target price on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating on the stock in a report on Wednesday, October 23rd. Stephens reissued an “overweight” rating and issued a $315.00 price target on shares of Danaher in a report on Wednesday, October 23rd. Wells Fargo & Company initiated coverage on Danaher in a research note on Tuesday, August 27th. They set an “equal weight” rating and a $280.00 price objective on the stock. Finally, Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 target price for the company in a research note on Thursday, October 31st. Five analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat, Danaher has an average rating of “Moderate Buy” and a consensus target price of $287.16.

Insider Buying and Selling at Danaher

In other news, SVP Georgeann Couchara sold 952 shares of the business’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $268.37, for a total transaction of $255,488.24. Following the transaction, the senior vice president now directly owns 4,212 shares in the company, valued at $1,130,374.44. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 10.90% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.